Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: Results from Diabetes MILES – Australia. (October 2017)

• Record Type: Journal Article
• Authors: Halliday, Jennifer A.; Hendrieckx, Christel; Busija, Lucy; Browne, Jessica L.; Nefs, Giesje; Pouwer, François; Speight, Jane
• Is Part Of: Diabetes research and clinical practice. Volume 132(2017)
• Page Start: 27
• Page End: 35
• Publication Date: 2017-10
• Subjects: Diabetes mellitus -- Depression -- Surveys and questionnaires -- Psychometrics -- Factor analysis, statistical -- ROC curve; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2017.07.005
• Languages: English
• ISSNs: 0168-8227

Abstract

Highlights: This is the first study of its kind among English-speaking adults with diabetes. The WHO-5 has satisfactory reliability (α = 0.90) and convergent and factorial validity. A WHO-5 cut-off of <13 is optimal to screen for likely depression. The WHO-5 is a suitable first-step screening instrument for likely depression. Abstract: Aims: Screening for depression is recommended internationally. The World Health Organization's 5-item Well-being Index (WHO-5) is used clinically to screen for depression but its empirical suitability for this purpose is not well documented. We investigated the psychometric properties of the WHO-5 and its suitability for identifying likely depression in Australian adults with diabetes. Methods: The Diabetes MILES – Australia study dataset provided a sample of N = 3249 who completed the WHO-5 (positively-worded 5-item measure of emotional well-being) and the PHQ-9 (9-item measure of depressive symptoms). Analyses were conducted for the full sample, and separately by diabetes type and treatment (type 1, non-insulin-treated type 2, and insulin-treated type 2 diabetes). Construct (convergent and factorial) validity and reliability of the WHO-5 were examined. ROC analyses were used to examine the sensitivity and specificity of the WHO-5 as a depression screening instrument, comparing two commonly used WHO-5 cut-off values (≤7 and <13) with the PHQ-9. Results: For the whole sample, the WHO-5 demonstrated satisfactory internal consistency reliability (α = 0.90) and convergent validity with the PHQ-9 (r = −0.73, p < 0.001). Confirmatory factor analysis partially supported factorial validity: Χ 2 (5) = 834.94, p < 0.001; RMSEA = 0.23, 90% CI 0.21–0.24; CFI = 0.98, TLI = 0.96; factor loadings = 0.78–0.92. The AUC was 0.87 (95% CI: 0.86–0.89, p < 0.001). The sensitivity/specificity of the WHO-5 for detecting likely depression was 0.44/0.96 for the ≤7 cut-off, and 0.79/0.79 for the <13 cut-off, with similar findings by diabetes type and treatment. Conclusions: These findings support use of a WHO-5 cut-point of <13 to identify likely depression in Australian adults with diabetes, regardless of type/treatment.